| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |